PhaseV reaps $15M in funding to streamline trial design with machine learning jkeenan Tue, 10/24/2023 - 09:04.: PhaseV, which uses machine learning to help design clinical trials, received a $15 million funding shot in the arm to expand its offerings and global reach. The Boston- and Tel Aviv-based company's platform allows clinical development teams to design studies and make real-time changes during the course of a trial in order to speed drug development more efficiently, the company said in an Oct. 24 press release.